Yesterday, Prilenia hosted a webinar updating on the Phase III trial with Pridopidine. Thank you to everyone who join and a special thanks to our speakers, Michael Hayden, Andrew Feigin, Ralf Reilman and Anne Rosser and also to Dina de Sousa for European Huntington Association. Stay tuned to see more events during May Awareness Month! 💙💜

Categories: NewsResearch


Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *



Skip to content